Innovations in Nicotinamide Mononucleotide (NMN) and Nuclear Medicine
Introduction NMN Conference 2025 in Vienna
The NMN Conference 2025, scheduled for May 9 and 10, 2025 at Palais Ferstel in Vienna, provides a unique platform for researchers, physicians, and specialists to discuss innovations around Nicotinamide Mononucleotide (NMN) and nuclear medicine. This international congress brings together leading experts to explore diagnostic and therapeutic advances, with a particular focus on NMN as a promising molecule in the field of longevity, metabolic health, and disease prevention.
With growing global interest in NAD+ metabolism and cellular aging, the NMN Conference in Vienna serves as an important meeting point for cutting-edge research, clinical applications, and interdisciplinary collaboration between oncology, neurology, and nuclear medicine.
What is Nicotinamide Mononucleotide (NMN)?
Nicotinamide Mononucleotide (NMN) is a direct precursor to NAD+ (nicotinamide adenine dinucleotide), a vital coenzyme involved in essential cellular processes such as energy production, DNA repair, mitochondrial function, and cellular aging. NAD+ levels naturally decline with age, which has been linked to fatigue, metabolic disorders, and age-related diseases.
At the NMN Conference 2025, researchers will present the latest findings on how NMN supplementation may help restore NAD+ levels, potentially supporting healthy aging, improving metabolic resilience, and contributing to the treatment of conditions such as neurodegenerative diseases and cancer.
Location: Palais Ferstel, Vienna
Vienna’s historic Palais Ferstel provides a prestigious and inspiring setting for in-depth scientific exchange. The combination of classical architecture and modern research discussions makes it an ideal location for a conference focused on innovation and future medical breakthroughs.
Key Topics and Innovations
The conference focuses on several important themes that highlight the intersection between NMN research and nuclear medicine:
1. Radioligand Therapy and Precision Medicine
Experts will discuss how NMN and radioligand therapy may complement each other in the treatment of cancers and other diseases. Particular attention is given to neuro-oncology, where targeted therapies and metabolic support may enhance treatment outcomes.
2. Molecular Imaging and NMN
Advanced imaging techniques will be presented, including PET scans and molecular imaging methods used to evaluate the effects of NMN on cellular health, metabolism, and tumor activity. These technologies enable researchers to better understand how NMN works inside the human body.
3. Theranostics with NMN
Theranostics—combining diagnostics and therapy—is a central theme of the conference. Researchers are exploring how NMN can be integrated into personalized treatment strategies, improving both detection and targeted intervention.
4. Bridging the Blood-Brain Barrier
One of the biggest challenges in treating brain-related conditions is delivering therapeutic compounds effectively into the brain. New techniques are being explored to improve the transport of NMN and other agents across the blood-brain barrier, opening new possibilities for treating brain tumors and neurodegenerative diseases.
5. NMN and Neurodegenerative Disorders
The role of NMN supplementation in addressing age-related neurological conditions such as Alzheimer’s and Parkinson’s disease will be discussed in depth. Researchers are particularly interested in how NMN may support neuronal health, reduce oxidative stress, and improve mitochondrial function.
Program Overview
The program includes a range of sessions specifically focused on NMN and its applications in modern medicine:
Friday, May 9, 2025
- 09:45 – 10:00: Introduction by Nathalie L. Albert and Matthias Preusser
- 10:00 – 12:00: Radioligand therapy, NMN, and precision oncology
- 13:00 – 14:00: Theranostics, NMN, and the application of radiopharmaceuticals
- 14:00 – 17:00: Abstract presentations highlighting recent NMN research
- 19:00: Networking event “Heurigen”
Saturday, May 10, 2025
- 09:00 – 10:00: “Coffee with the Editors”
- 10:00 – 12:00: Sessions on NMN, brain tumors, and intra-arterial therapies
- 13:30 – 15:00: Interdisciplinary discussions on NMN, oncology, and neurodegeneration
- 15:45 – 17:00: PET imaging of CNS tumors with a focus on NMN applications
Speakers and Experts
Prominent experts such as Dr. Nathalie L. Albert and Prof. Matthias Preusser will share their insights on NMN applications in neuro-oncology and broader medical innovation. Their work contributes significantly to the understanding of how metabolic therapies like NMN can be integrated into clinical practice.
Registration and Participation
Registration for the NMN Conference 2025 is available through the official conference page, with early registration opportunities open until February 28, 2025. Due to the growing interest in NMN research and longevity science, early registration is recommended.
Conclusion
The NMN Conference 2025 offers a comprehensive platform to explore innovations in Nicotinamide Mononucleotide and nuclear medicine. It is an essential event for professionals interested in longevity science, precision medicine, and the future of healthcare.
By bringing together experts from multiple disciplines, the conference highlights the growing importance of NMN in both research and clinical applications, positioning it as a key molecule in the future of healthy aging.
More information and registration are available via the NMN Society.
External sources:
Join the NMN Conference 2025 and discover the future of medical innovation and health!
